Clinical Trial Update: A Proof-of-concept Trial to Evaluate the Safety and Efficacy of UB-421 Plus Chidamide in Changing HIV Reservoirs [Phase 2]

View source ↗

Summary

Phase 2 proof-of-concept trial evaluating UB-421 plus chidamide for safety and efficacy in changing HIV reservoirs has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Chidamide (chidamide)
• UB-421 (anti-CD4 antibody)

Snippet

Sponsor: United BioPharma | Conditions: HIV-1 Infection | Phase 2 | Status: COMPLETED